Mark V. Pauly

Q: What Schools Are Affiliated With Mark V. Pauly

Mark V. Pauly is affiliated with the following schools: University of Delaware, University of Virginia, University of Pennsylvania

Mark V. Pauly's AcademicInfluence.com Rankings

Mark V. Pauly

Economics

#1419

World Rank

#1638

Historical Rank

economics Degrees

Download Badge

Economics

Why Is Mark V. Pauly Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Mark V. Pauly is an American economist whose work focuses on healthcare management and business economics. He is currently the Bendheim Professor in the Department of Health Care Management at the Wharton School of the University of Pennsylvania. Pauly is a former commissioner on the Physician Payment Review Commission, and has been a consultant to the Congressional Budget Office, the Office of the Secretary of the U.S. Department of Health and Human Services, the American Enterprise Institute, and served on the Medicare Technical Advisory Panel. He is also the Co-Editor-in-Chief of the Springer journal International Journal of Health Care Finance and Economics, and was formerly the Robert D. Eilers Professor from 1984 to 1989.

(See a Problem?)

Mark V. Pauly's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Comprehensive discharge planning and home follow-up of hospitalized elders: a randomized clinical trial. (1999) (1347)
Readings in the economics of contract law: The economics of moral hazard: comment (1982) (991)
A randomized, controlled trial of financial incentives for smoking cessation. (2009) (860)
Overinsurance and Public Provision of Insurance: The Roles of Moral Hazard and Adverse Selection (1974) (662)
The Not-For-Profit Hospital as a Physicians' Cooperative (1973) (545)
How do financial incentives affect physicians' clinical decisions and the financial performance of health maintenance organizations? (1989) (480)
Comprehensive Discharge Planning for the Hospitalized Elderly (1994) (474)
Physician response to fee changes with multiple payers. (1991) (429)
Taxation, health insurance, and market failure in the medical economy. (1986) (391)
Income redistribution as a local public good (1973) (390)
The Rational Nonpurchase of Long-Term-Care Insurance (1990) (354)
Carrier Screening for Cystic Fibrosis (1998) (350)
Comprehensive discharge planning for the hospitalized elderly. A randomized clinical trial. (1994) (347)
Universal health insurance in the Clinton plan: coverage as a tax-financed public good. (1994) (346)
Estimating hospital costs. A multiple-output analysis. (1986) (343)
Neglecting Disaster: Why Don't People Insure Against Large Losses? (2004) (307)
Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies. (1991) (258)
Integrated delivery networks: a detour on the road to integrated health care? (2002) (258)
Predictors of type of vascular access in hemodialysis patients. (1996) (249)
The pricing of primary care physicians' services: a test of the role of consumer information (1981) (235)
Epidemiology of Interstitial Cystitis: 2 (1990) (234)
Doctors and Their Workshops: Economic Models of Physician Behavior (1981) (193)
Compensation and Productive Efficiency in Partnerships: Evidence from Medical Groups Practice (1990) (193)
Measuring the Effects of Workloss on Productivity with Team Production (2004) (187)
Survival analysis of patients undergoing dialysis. (1987) (183)
Mortality and duration of hemodialysis treatment. (1991) (179)
A general model of the impact of absenteeism on employers and employees. (2002) (167)
Insurance and Behavioral Economics: Improving Decisions in the Most Misunderstood Industry (2013) (164)
Continuity of Care: The Transitional Care Model. (2015) (161)
First-cycle blood counts and subsequent neutropenia, dose reduction, or delay in early-stage breast cancer therapy. (1998) (157)
Valuing reductions in on-the-job illness: 'presenteeism' from managerial and economic perspectives. (2008) (156)
Alternative Valuations of Work Loss and Productivity (2001) (155)
Nonprofit firms in medical markets. (1987) (152)
High-value transitional care: translation of research into practice. (2011) (151)
P4P4P: an agenda for research on pay-for-performance for patients. (2009) (144)
Access to conventional medical care and the use of complementary and alternative medicine. (2005) (136)
Guaranteed renewability in insurance (1995) (133)
Group Health Insurance as a Local Public Good (1976) (132)
Contractual Arrangements Between HMOs and Primary Care Physicians: Three-Tiered HMOs and Risk Pools (1992) (124)
Access to kidney transplantation. Has the United States eliminated income and racial differences? (1988) (122)
Time preference and its relationship with age, health, and survival probability. (2009) (118)
Accountable care organizations may have difficulty avoiding the failures of integrated delivery networks of the 1990s. (2012) (114)
An Overview of Value, Perspective, and Decision Context-A Health Economics Approach: An ISPOR Special Task Force Report [2]. (2018) (112)
Optimality, "Public" Goods, and Local Governments: A General Theoretical Analysis (1970) (109)
Hospital adoption of medical technology: an empirical test of alternative models. (1995) (109)
Pooling Health Insurance Risks (1999) (107)
Private health insurance in developing countries. (2006) (106)
Assessing the value of a new pharmaceutical. A feasibility study of contingent valuation in managed care. (1998) (105)
Competition and efficiency in the end stage renal disease program. (1983) (105)
Cost Functions for a Service Firm with Variable Quality and Stochastic Demand: The Case of Hospitals (1981) (105)
Financial incentives and drug spending in managed care. (1999) (100)
A Health Economics Approach to US Value Assessment Frameworks-Summary and Recommendations of the ISPOR Special Task Force Report [7]. (2018) (100)
Spillovers and vulnerability: the case of community uninsurance. (2007) (99)
Doctors and Their Workshops (1980) (99)
Life insurance and breast cancer risk assessment: Adverse selection, genetic testing decisions, and discrimination (2003) (98)
A plan for 'responsible national health insurance'. (1991) (98)
End-stage renal disease and economic incentives: the International Study of Health Care Organization and Financing (ISHCOF) (2007) (97)
Valuing health care: Valuing health care benefits in money terms (1995) (94)
Measuring community benefits provided by for-profit and nonprofit hospitals. (2000) (94)
Cores and clubs (1970) (93)
Market reform in New Jersey and the effect on mortality from acute myocardial infarction. (2003) (92)
Effect of Tiered Prescription Copayments on the Use of Preferred Brand Medications (2003) (91)
Is cream-skimming a problem for the competitive medical market? (1984) (87)
Community-level uninsurance and the unmet medical needs of insured and uninsured adults. (2006) (86)
Market equilibrium with private knowledge : An insurance example (1985) (86)
Is medical care different? Old questions, new answers. (1988) (83)
Medicare drug coverage and moral hazard. (2004) (83)
Estimating Adverse Selection Costs from Genetic Testing for Breast and Ovarian Cancer: The Case of Life Insurance (1999) (81)
Effect of dialyzer reuse on survival of patients treated with hemodialysis. (1996) (79)
Moral hazard in insurance, value-based cost sharing, and the benefits of blissful ignorance. (2008) (79)
Access to Kidney Transplantation: Has the United States Eliminated Income and Racial Differences? (1988) (79)
Transitions of Elders Between Long-Term Care and Hospitals (2009) (78)
Tax credits for health insurance and medical savings accounts. (1995) (78)
Tiebout bias on the demand for local public goods (1981) (78)
Adverse Selection and the Challenges to Stand-Alone Prescription Drug Insurance (2003) (77)
Toward new typologies for HMOs. (1990) (76)
Clubs, Commonality, and the Core: An Integration of Game Theory and the Theory of Public Goods (1967) (76)
The nongroup health insurance market: short on facts, long on opinions and policy disputes. (2002) (74)
Health Benefits at Work: An Economic and Political Analysis of Employment-Based Health Insurance (1998) (73)
Incentive-compatible guaranteed renewable health insurance premiums. (2006) (72)
Comparison of evidence-based interventions on outcomes of hospitalized, cognitively impaired older adults. (2014) (72)
Time, Risk, Precommitment, and Adverse Selection in Competitive Insurance Markets (2003) (71)
Risk pooling and regulation: policy and reality in today's individual health insurance market. (2007) (71)
Price transparency for medical devices. (2008) (70)
Medical staff characteristics and hospital costs. (1978) (70)
Expanding coverage via tax credits: trade-offs and outcomes. (2001) (68)
Health Care Spending Risk, Health Insurance, and Payment to Health Plans (2011) (68)
Price of dialysis, unit staffing, and length of dialysis treatments. (1990) (67)
Dialysis Outcomes and Practice Patterns Study (DOPPS) data on medications in hemodialysis patients. (2004) (66)
Handbook of Health Economics Volume 2 (2011) (64)
Hospital output forecasts and the cost of empty hospital beds. (1986) (64)
Managed care, market power, and monopsony. (1998) (63)
Comorbidity-adjusted complication risk: a new outcome quality measure. (1996) (62)
Transformation of the Health Care Industry: Curb Your Enthusiasm? (2018) (60)
Incentive effects of medical malpractice. The effects of malpractice litigation on physicians' fees and incomes. (1990) (59)
Individual versus job-based health insurance: weighing the pros and cons. (1999) (59)
Cost function estimation and quality bias: the regulated automobile insurance industry (1986) (58)
Modeling the cost-effectiveness of granulocyte colony-stimulating factor use in early-stage breast cancer. (1998) (57)
Health Insurance and the Growth in Pharmaceutical Expenditures* (2002) (56)
Chronic Illness, Treatment Choice and Workforce Participation (2004) (56)
Benign moral hazard and the cost-effectiveness analysis of insurance coverage. (1990) (55)
THE WELFARE ECONOMICS OF COMMUNITY RATING (1970) (55)
Financing health care. (1990) (55)
A New Approach to Hospital Cost Functions and Some Issues in Revenue Regulation (1983) (53)
The impact of Computer-assisted Test Interpretation on Physician Decision Making (1997) (52)
Price Elasticity of Demand for Term Life Insurance and Adverse Selection (2003) (52)
Cost and Performance: A Comparison of the Individual and Group Health Insurance Markets (2000) (52)
More on moral hazard. (1983) (51)
Engaging older adults in their transitional care: what more needs to be done? (2013) (50)
Guaranteed renewability and the problem of risk variation in individual health insurance markets. (2002) (49)
Efficiency in the Provision of Consumption Subsidies (1970) (49)
Is thirty-day hospital mortality really lower for black veterans compared with white veterans? (2007) (49)
Objectives, Budgets, Thresholds, and Opportunity Costs-A Health Economics Approach: An ISPOR Special Task Force Report [4]. (2018) (49)
A re-examination of the meaning and importance of supplier-induced demand. (1994) (49)
Managing Physician Incentives in Managed Care: The Role of For-Profit Ownership (1990) (48)
Regulation and Quality Competition in the US Insurance Industry (1986) (47)
HMO managers' views on financial incentives and quality. (1991) (46)
The Ethics and Economics of Kickbacks and Fee Splitting (1979) (45)
Adaptations of the evidence-based Transitional Care Model in the U.S. (2018) (44)
Responsible National Health Insurance (1992) (43)
The Role of Insurance in the Allocation of Risk (1971) (43)
An efficient employer strategy for dealing with adverse selection in multiple-plan offerings: an MSA example. (2000) (42)
Competition and new technology. (2005) (42)
Short- and long-term mortality after an acute illness for elderly whites and blacks. (2008) (42)
Adverse Selection in Term Life Insurance Purchasing Due to the BRCA1/2 Genetic Test and Elastic Demand (2007) (41)
The Economics of Insurance Regulation (1986) (41)
M. Naylor, D. Brooten, R. Campbell, B. Jacobsen, M. Mezey, M. Pauly, J. Schwartz. Comprehensive discharge planning and home follow-up of hospitalized elders. JAMA: Journal of the American Medical Association, 281, 613-620. (1999) (2011) (41)
Bending the cost curve through market-based incentives. (2012) (40)
Insurance and new technology: from hospital to drugstore. (2001) (40)
Competition in Medical Services and the Quality of Care: Concepts and History (2004) (40)
A model of local government expenditure and tax capitalization (1976) (39)
Health Maintenance Organizations and Hospital Quality for Coronary Artery Bypass Surgery (1999) (38)
The Medicare Cost of Renal Dialysis: Evidence From a Statistical Cost Function (1992) (38)
Competitive behavior in the HMO marketplace. (2002) (37)
Bending the curve: effective steps to address long-term healthcare spending growth. (2009) (37)
U.S. health care costs: the untold true story. (1993) (36)
How to present the business case for healthcare quality to employers (2005) (36)
Should we be worried about high real medical spending growth in the United States? (2003) (36)
Would you like suspenders to go with that belt? An analysis of optimal combinations of cost sharing and managed care. (1999) (35)
Association of dialyzer reuse with hospitalization and survival rates among U.S. hemodialysis patients: do comorbidities matter? (1999) (35)
Reserve Levels and Reserve Requirements for Profit-Maximizing Insurance Firms (1984) (34)
Physician opportunity costs in physician practice cost functions. (1998) (34)
Market power, monopsony, and health insurance markets. (1988) (34)
Health maintenance organization penetration and the practice location choices of new physicians: a study of large metropolitan areas in the United States. (1998) (34)
Physicians’ career satisfaction, quality of care and patients’ trust: the role of community uninsurance (2007) (33)
Poor health kills small business: illness and microenterprises in South Africa. (2007) (32)
How risky is individual health insurance? (2008) (32)
Medical Care At Public Expense: A Study in Applied Welfare Economics (1971) (32)
Improving vaccine supply and development: who needs what? (2005) (32)
Monopsony power in health insurance: thinking straight while standing on your head. (1987) (31)
Unnecessary surgery. (1979) (31)
HIV/AIDS stigma attitudes among educators in KwaZulu-Natal, South Africa. (2010) (30)
Is Lower 30-Day Mortality Posthospital Admission Among Blacks Unique to the Veterans Affairs Health Care System? (2007) (29)
Impact of Maine's Medicaid drug formulary change on non-Medicaid markets: spillover effects of a restrictive drug formulary. (2003) (29)
The Effect of State Community Rating Regulations on Premiums and Coverage in the Individual Health Insurance Market (2006) (29)
What is adverse about adverse selection? (1985) (29)
Health Risk, Income, and Employment-Based Health Insurance (2005) (29)
Measuring Hospital Outcomes from a Buyer's Perspective (1996) (28)
Alternative Compensation Arrangements and Productive Efficiency in Partnerships: Evidence from Medical Group Practice (1987) (28)
Getting real performance out of pay-for-performance. (2008) (28)
Adverse Consequences of Adverse Selection (1999) (26)
Premium Variation in the Individual Health Insurance Market (2001) (25)
Economics of Multispecialty Group Practice (1996) (25)
Almost optimal social insurance for long-term care. (1996) (25)
Who was that straw man anyway? A comment on Evans and Rice. (1997) (25)
Linkages Between Nursing and the Quality of Patient Care: A 2-Year Comparison (2013) (24)
Spillover Effects of Restrictive Drug Formularies on Physician Prescribing Behavior: Evidence from Medicaid (2005) (24)
Dynamic Insurance Decision-Making for Rare Events: The Role of Emotions (2018) (24)
Practice Guidelines: Can They Save Money? Should They? (1995) (24)
The Role of MD and MBA Training in the Professional Development of a Physician: A Survey of 30 Years of Graduates From the Wharton Health Care Management Program (2014) (23)
Financing Vaccination of Children and Adolescents: National Vaccine Advisory Committee Recommendations (2009) (23)
Structural incentives and adoption of medical technologies in HMO and fee-for-service health insurance plans. (1997) (23)
Supplying vaccines : an economic analysis of critical issues (1996) (23)
Commentary: Medical Savings Accounts in Singapore: What Can We Know? (2001) (23)
Genetic screening for reproductive planning: methodological and conceptual issues in policy analysis. (1996) (22)
Effects of Insurance Coverage on Use of Care and Health Outcomes for Nonpoor Young Women. (2005) (22)
Guaranteed Renewability with Group Insurance (1998) (22)
Optimal Health Insurance (2000) (21)
Maryland exceptionalism? All-payers regulation and health care system efficiency. (2012) (21)
Making America More Resilient toward Natural Disasters: A Call for Action (2013) (21)
When does curbing health costs really help the economy? (1995) (21)
Making Sense of a Complex System: Empirical Studies of Employment-Based Health Insurance (2001) (21)
Controlling Medicaid Costs: Federalism, Competition and Choice (1983) (21)
A measure of the welfare cost of health insurance. (1969) (20)
The Demand for Health Insurance in the Group Setting: Can You Always Get What You Want? (2007) (20)
Primary care physician turnover in HMOs. (1994) (19)
Analysis & commentary: The trade-off among quality, quantity, and cost: how to make it--if we must. (2011) (19)
The changing health care environment. (1986) (19)
Economic Issues in Reform of Health Care Financing (1994) (19)
The Questionable Economic Case for Value-Based Drug Pricing in Market Health Systems. (2017) (18)
How Important is the Scientific Literature in Guiding Clinical Decisions?: The Case of Magnetic Resonance Imaging (1993) (18)
The Effect of Tax-Exempt Out-of-Pocket Premiums on Health Plan Choice (2001) (18)
How private, voluntary health insurance can work in developing countries. (2009) (18)
Is high and growing spending on cancer treatment and prevention harmful to the United States economy? (2007) (17)
Excess Burden and the Voluntary Theory of Public Finance (1969) (17)
Insurance and Behavioral Economics (2013) (17)
Bending the curve through health reform implementation. (2010) (17)
Competition in health insurance markets. (1988) (17)
Association of Dialyzer Reuse and Hospitalization Rates among Hemodialysis Patients in the US (1999) (17)
Is There a Market for Voluntary Health Insurance in Developing Countries? (2008) (17)
National health insurance : what now, what later, what never? (1980) (16)
An analysis of medical savings accounts : do two wrongs make a right? (1994) (16)
The Economics of Insurance Regulation: A Cross-National Study (1986) (16)
Incentive-Compatible Guaranteed Renewable Health Insurance (2003) (16)
Out-of-pocket expenses and treatment choice for men with prostate cancer. (2012) (16)
The Double Liability Rule (1990) (16)
Guaranteed renewability uniquely prevents adverse selection in individual health insurance (2011) (16)
Death Spiral or Euthanasia? The Demise of Generous Group Health Insurance Coverage (2004) (15)
Returns on equity for not-for-profit hospitals. (1986) (15)
Paying physicians : options for controlling cost, volume, and intensity of services (1992) (15)
Comparative effectiveness and cost-effectiveness analyses frequently agree on value. (2015) (15)
Social Impact Bonds in Nonprofit Health Care: New Product or New Package? (2013) (15)
Market Equilibrium with Private Knowledge (1985) (15)
Tax Credits, the Distribution of Subsidized Health Insurance Premiums, and the Uninsured (2001) (15)
Accountable Care Organizations May Have Difficulty Avoiding The Failures Of Integrated Delivery Networks Of The 1990 s (2012) (15)
A Randomized Clinical Trial (1994) (15)
Privatization and bidding in the health-care sector. (1987) (15)
How will changes in physician payment by Medicare influence laboratory testing? (1987) (14)
The evolution of health insurance in India and China. (2008) (14)
Who Pays? The Incidence of High Malpractice Premiums (2006) (14)
Risk and the Social Rate of Discount (1970) (14)
Optimal Public Subsidies of Nursing Home Insurance in the United States (1989) (13)
Adverse Selection and Moral Hazard: Implications for Health Insurance Markets (2008) (13)
Accountable care organizations and kidney disease care: health reform innovation or more same-old, same-old? (2012) (13)
Medicaid Everyone Can Count On: Public Choices for Equity and Efficiency (2010) (13)
10. Insuring against Catastrophes (2010) (13)
Terrorism Losses and All Perils Insurance (2005) (13)
TOO SICK TO START: ENTREPRENEUR'S HEALTH AND BUSINESS ENTRY IN TOWNSHIPS AROUND DURBAN, SOUTH AFRICA. (2010) (13)
Behavioral economics and insurance: Principles and solutions (2015) (13)
'We aren't quite as good, but we sure are cheap': prospects for disruptive innovation in medical care and insurance markets. (2008) (12)
Information Technology and Consumer Search for Health Insurance (2006) (12)
Time Preference and Its Relationship with Age, Health, and Longevity Expectations (2007) (12)
Predictors of Type of Vascular Access in Hemodialysis Patients (1997) (12)
ON THE INCIDENCE OF TAX DEDUCTIBILITY (1970) (12)
Health Reform without Side Effects: Making Markets Work for Individual Health Insurance (2010) (12)
Effects of alternative interventions among hospitalized, cognitively impaired older adults. (2016) (12)
Contemporary considerations in the treatment of hypertension. Cost, efficacy, and preference. Proceedings of a symposium. September 14, 1986, Washington, D.C. (1986) (12)
Means-testing in Medicare. (2004) (12)
CUTTING TAXES FOR INSURING : OPTIONS AND EFFECTS OF TAX CREDITS FOR HEALTH INSURANCE (1999) (12)
Blending better ingredients for health reform. (2008) (12)
American health care : government, market processes, and the public interest (2000) (11)
Social Impact Bonds: New Product or New Package? (2017) (11)
When Should Medicare Mandate Participation In Alternative Payment Models? (2020) (11)
Hospital Capital Investment: The Roles of Demand, Profits, and Physicians (1974) (11)
Introduction: The Interdisciplinary Nursing Quality Research Initiative (2013) (11)
Health systems ownership: can regulation preserve community benefits? (1996) (11)
Asymmetric Thinking about Return on Investment. (2016) (11)
“Sticker Shock” in Individual Insurance under Health Reform? (2014) (11)
Cost impact of the transitional care model for hospitalized cognitively impaired older adults. (2017) (11)
Risk variation and fallback insurers in universal coverage insurance plans. (1992) (10)
Perceptions of Community HIV Prevalence, Own HIV Infection, and Condom Use among Teachers in KwaZulu-Natal, South Africa (2007) (10)
The Effects of Health Insurance on Access to New Medical Technologies (1997) (10)
Complementary and alternative medicine: personal preference or low cost option? (2004) (10)
Research on competition in the market for health services: problems and prospects. (1983) (10)
Crisis facing HCFA & millions of Americans. (1999) (10)
Health Employment, Medical Spending, and Long Term Health Reform (2011) (10)
The normative and positive economics of minimum health benefits. (1992) (10)
End-Stage Renal Disease and Economic Incentives: The International Study of Health Care Organization and Financing (2007) (10)
Making a case for employer-enforced individual mandates. (1994) (9)
Public protection against misperceived risks: Insights from positive political economy (1984) (9)
Effects of the ACA on Health Care Cost Containment. (2017) (9)
A COMPARATIVE EVALUATION OF TWO INTERVENTIONS FOR EDUCATOR TRAINING IN HIV/AIDS IN SOUTH AFRICA. (2010) (9)
Difference in the use of preventive services between fee-for-service plans and HMOs: is more better? (2003) (9)
Risks and benefits in health care: the view from economics. (2007) (9)
M. Naylor, D. Brooten, R. Jones, R. Lavizzo-Mourey, M. Mezey, M. Pauly. Comprehensive discharge planning for hospitalized elderly: A randomized clinical trial. Annals of Internal Medicine, 120, 999-1006. (1994) (2011) (9)
Reply to Roberta Labelle, Greg Stoddart and Thomas Rice (1994) (9)
Chapter 10 - Insurance Reimbursement (2000) (9)
Lessons from the first twenty years of medicare : research implications for public and private sector policy (1988) (9)
Health Insurance on the Internet and the Economics of Search (2002) (8)
Paying a return on equity to not-for-profit hospitals--some further thoughts. (1987) (8)
The Truth About Moral Hazard and Adverse Selection (2007) (8)
Avoiding the mistreatment of bad risks in a democracy: Universal Health Insurance from a constitutional perspective (1994) (8)
Continuous ambulatory peritoneal dialysis: preliminary evidence in the debate over efficacy and cost. (1983) (8)
Insurance incentives for ambulatory surgery. (1993) (8)
What if technology never stops improving? Medicare's future under continuous cost increases. (2004) (7)
"Play-or-pay" insurance reforms for employers--confusion and inequity. (2010) (7)
Health care reform in perspective. (2009) (7)
PRIVATE HEALTH INSURANCE EXCHANGES (2013) (7)
Ranking hospitals by the quality of care for medical conditions: the role of complications. (1996) (7)
An economic framework for preventive care advice. (2014) (7)
The Price of Responsibility: The Impact of Health Reform on Non-Poor Uninsureds (2015) (7)
The Medicare mix: efficient and inefficient combinations of social and private health insurance for U.S. elderly. (2000) (7)
Dynamic Insurance Decision-Making for Rare Events: The Role of Emotions (2015) (7)
Medical Savings Accounts: The Authors Respond (1995) (7)
Why the United States does Not Have Universal Health Insurance: A Public Finance and Public Choice Perspective (2002) (7)
Time savings – realized and potential – and fair compensation for community health workers in Kenyan health facilities: a mixed-methods approach (2015) (7)
An Adaptive Credit Plan for Covering the Uninsured (2001) (7)
Alternative valuation of work loss and productivity, Health and Productivity Management Center (2001) (7)
Increasing the Value of Health Care: The Role of Nurses (2015) (6)
Is it time to reexamine the patent system's role in spending growth? (2009) (6)
Avoiding side effects in implementing health insurance reform. (2010) (6)
Cost-effectiveness analysis and insurance coverage: solving a puzzle. (2015) (6)
Coordination of Care or Conflict of Interest? Exempting ACOs from the Stark Law. (2019) (6)
Public insurance of private risks: theory and evidence from agriculture (1993) (6)
Pharmaceutical Innovation: Measures of Costs and Benefits for Drugs in Cost-Effectiveness Analysis (2007) (6)
Equilibrium in Insurance Markets with Experience Rating (1983) (6)
Insurance and Drug Spending (2012) (6)
Limiting the Tax Exclusion for Employment-based Health Insurance: Are Improved Equity and Efficiency Enough? (2009) (5)
Conflict and Compromise over Tradeoffs in Universal Health Insurance Plans (2004) (5)
The Tax Subsidy to Employment-Based Health Insurance and the Distribution of Well-Being (2006) (5)
How Nursing Affects Medicare’s Outcome-Based Hospital Payments (2015) (5)
Value Based Cost Sharing Meets the Theory of Moral Hazard: Medical Effectiveness in Insurance Benefits Design (2007) (5)
"The study on surgical services for the United States": a valid prescription for American surgery? (1977) (5)
Cost Sharing in Insurance Coverage for Precision Medicine (2017) (5)
Paying Physicians as Agents: Fee-For-Service, Caption, or Hybrids? (1995) (5)
Developing a Policy Flight Simulator to Facilitate the Adoption of an Evidence-Based Intervention (2018) (5)
National health insurance : an analysis (1971) (5)
The Clinton plan: what happened to the tough choices? (1994) (5)
Endogenous Productivity of Demand-Induced R&D: Evidence from Pharmaceuticals (2019) (5)
Drug and vaccine pricing and innovation: what is the story? (2007) (4)
Losses (and Gains) from Health Reform for Non‐Medicaid Uninsureds (2018) (4)
The new Medicare drug benefit: much ado about little? (2004) (4)
Do Workers Bear the Cost of Rising Health Insurance Premiums through Lower Wage Raises (2009) (4)
Insurance and the Demand for Medical Care (2011) (4)
Medical Malpractice and the U.S. Health Care System: Who Pays When Malpractice Premiums Rise? (2006) (4)
Keeping health insurance tax credits on the table. (2004) (4)
Will Medicare reforms increase managed care enrollment? (1996) (4)
From hospital to drugstore: insurance and the shift to outpatient care. (2001) (4)
MIRROR-TCM: Multisite replication of a randomized controlled trial - Transitional care model. (2021) (4)
Clinical quality initiatives: The search for meaningful- and accurate- measures (1992) (4)
19 – OVERINSURANCE AND PUBLIC PROVISION OF INSURANCE: THE ROLES OF MORAL HAZARD AND ADVERSE SELECTION * (1978) (4)
Equity and Costs (1985) (4)
Fairness and feasibility in national health care systems. (1992) (4)
Reply to Anthony J. Culyer and Robert G. Evans (1996) (4)
10 myths of the uninsured. (2004) (4)
Spillover effects of restrictive drug formularies: a case study of PacifiCare in California. (2005) (4)
Market Insurance, Public Insurance and the Rate of Technical Change in Medical Care (2003) (4)
Patient Protection and Affordable Care Act cost-containment choices: the case for incentive-based approaches. (2011) (4)
Insurance and Behavioral Economics: Notes (2013) (4)
Regulation of Bad Things That Almost Never Happen but Could: HIPAA and the Individual Insurance Market (2002) (4)
Mortality and Duration of Hemodialysis Treatment-Reply (1991) (3)
What You Don't Know Can Hurt You: Terrorism Losses and All Perils Insurance* (2004) (3)
What is unnecessary surgery? (1979) (3)
Market reform in New Jersey and quality of care: a cautionary tale. (2003) (3)
Should Lower-Income People Be Allowed to Buy Insurance with High Cost Sharing? (2016) (3)
Vaccines as Epidemic Insurance (2017) (3)
How Private Health Insurance Pools Risk (2005) (3)
Manpower Shortages in Local Government Employment: Discussion (1969) (3)
Adding Demand, Incentives, Disequilibrium, and Disaggregation to Health Care Models (1981) (3)
Preventive care in managed care and fee-for-service plans: is it cost effective? (2003) (3)
The Role of Physicians in the Production of Hospital Output (1975) (3)
Physician Payment Reform: Who Shall Be Paid? (1986) (3)
Pro-competitive health insurance proposals and their implications for medicare's end stage renal disease program (1982) (3)
Bibliography of recent works in non-market decision making (1967) (3)
4. The Problems with Estimates (2003) (3)
The unanticipated consequences of postponing the employer mandate. (2013) (3)
Single vs multiple embryo transfer: comparative costs and a call for change. (2014) (3)
Financing Long-Term Care: What Should Be the Government's Role? (1996) (3)
Do people have a bias for low deductible insurance? (2020) (2)
Recruiting health care rationers: Individual versus collective choice (2002) (2)
Public health care and health insurance reform--varied preferences, varied options. (2009) (2)
IGNORING DISASTER: DON’T SWEAT THE BIG STUFF (2001) (2)
Managing Discovery in the Life Sciences: Harnessing Creativity to Drive Biomedical Innovation (2018) (2)
Accountable care organizations: back to the future? (2012) (2)
Lessons to improve the efficiency and equity of health reform. (2012) (2)
Massachusetts Evades Employer Mandates: Lessons for Other States? (2008) (2)
Behavioral Economics of Multiperiod Insurance Purchasing Behavior: The Role of Emotions (2018) (2)
Handbook of Health Economics (2000) (2)
Reply to Ralph Bradley, “Comment – Defining health insurance affordability: Unobserved heterogeneity matters” ☆ (2009) (2)
How Stable Are Insurance Subsidies in Health Reform? (2010) (2)
Kenneth Arrow and the changing economics of health care. Forward. (2001) (2)
Wussinomics: the state of competitive efficiency in private health insurance (2012) (2)
Physician Information and the Consumer's Demand for Care (1980) (2)
James Buchanan as a Health Economist (2002) (2)
Primary Care Shortages: More Than a Head Count (2014) (2)
Physicians' payment and their prescription of laboratory tests: the effects on clinical laboratory services of selected alternatives for paying physicians under the Medicare program (1985) (2)
Spillovers And Vulnerability: The Case Of Community (2007) (2)
How Does Cost-Sharing Impact Spending Growth and Cost-Effective Treatments? Evidence from Deductibles (2020) (1)
Health Affairs insurance ' A plan for ' responsible national health (2001) (1)
Medical Spending Reform and the Fiscal Future of the United States (2011) (1)
Will Health Care's Immediate Future Look a Lot like the Recent Past? MORE PUBLIC-SECTOR FUNDING, BUT MORE PRIVATE-SECTOR DELIVERY AND ADMINISTRATION, TOO (2019) (1)
Physicians as Agents (1980) (1)
Too Sick To Start: Health of the Entrepreneur and Business Entry in Townships around Durban, South Africa (2008) (1)
Reflections on using physician agents to minimize the cost of health. (1985) (1)
HMO behavior and stock market valuation: what does Wall Street reward and punish? (2001) (1)
POLICY FLIGHT SIMULATORS: ACCELERATING DECISIONS TO ADOPT EVIDENCE-BASED HEALTH INTERVENTIONS (2018) (1)
Financement public et marchés privés en assurance santé...un mélange délicat. Mix Without Stirring : Public Finance and Private Markets in Health Insurance (2005) (1)
Insurance Market Equilibria with Credibility Adjusted Premiums (1983) (1)
Community benefits: how do for-profit and nonprofit hospitals measure up? (2000) (1)
Physicians and Hospitals (1980) (1)
Producing Research on Health Management and Managed Care: Market Failure or Market Success? (1996) (1)
Does High Cost-Sharing Slow the Long-Term Growth Rate of Health Spending? Evidence from the States (2018) (1)
Is There a Future for Employer- Sponsored Health Insurance? (2015) (1)
Health Maintenance Organizations and the Changing Physician Workforce (2001) (1)
Health Policy and Practice in the United States (1998) (1)
Can Insurance Cause Medical Care Spending to Grow too Rapidly (2002) (1)
Mixed Public and Private Financing of Education: Reply (1969) (1)
AND HOSPITAL COSTS (2016) (1)
A Better (but Modest) Case for High-Risk Pools (2017) (1)
Detecting BS in Health Care (2018) (1)
What if technology never stops improving? Medicare's future under continuous cost increases. (2003) (1)
Costs and Benefits of Branded Drugs: Insights from Cost-Effectiveness Research (2022) (1)
Individually underwritten coverage often gets the blame for uninsurance that results from problems in the group coverage market. (2008) (1)
The Economic Costs of Newly Diagnosed Lyme Disease (1994) (1)
Beyond “Sicko”— Thoughts on Health System Reform (2007) (1)
Financing treatment for substance abuse. (1991) (1)
Competitive behavior in the HMO marketplace: HMOs do not appear to extract more profits from consumers in markets dominated by for-profit firms than in markets where their share is smaller. (2002) (1)
Hospital characteristics and physician productivity and fee levels. (1982) (1)
The Public Policy Implications of Using Outcome Statistics (1992) (1)
Policy Flight Simulators: Accelerating Decisions to Adopt Evidence-Based Health Interventions. (2019) (1)
Measuring hospital ambulatory care costs. (1981) (1)
Some observations on greater competition in the West German health‐insurance system from a US perspective (1986) (1)
THE EFFECT OF REVENUE AND TAX LIMITATION ON PROPERTY VALUES (1979) (1)
The vagaries of making distributional assumptions. (1995) (1)
How health affects small business in South Africa. (2007) (0)
Insurance and Behavioral Economics: Real-World Complications (2013) (0)
Hospital Beds, Hospital-oriented Physicians, and Hospital Use (1980) (0)
Considering the Economic Case for Value-Based Pricing in the U.S (2016) (0)
Choosing long-term care insurance. (2001) (0)
Descriptive Models of Insurance Supply (2012) (0)
PHASE II: QUALITATIVE ASSESSMENT OF ADAPTATIONS OF THE TRANSITIONAL CARE MODEL. (2017) (0)
Insurance and Behavioral Economics: Why People Do or Do Not Demand Insurance (2013) (0)
What the Market Signals Are Saying (2008) (0)
Publicly Provided Social Insurance (2012) (0)
Managing The Discovery Factory: Can Innovation Be Organized? (2006) (0)
Medical employment growth, unemployment, and the opportunity cost of health care (2016) (0)
The clinton health reform (1994) (0)
Behavior Consistent with Benchmark Models (2012) (0)
Front matter, table of contents, acknowledgments (1980) (0)
Aim Your Enthusiasm: Targeting Increased Middle Class Health Insurance Tax Credits (2021) (0)
Books received (1993) (0)
Insurance and Behavioral Economics: Anomalies and Rumors of Anomalies (2013) (0)
Impact of “Time to Transplant” On Recurrence of Hepatocellular Carcinoma (HCC).: Abstract# A401 (2014) (0)
Betting on Bending the Cost Curve (2011) (0)
Understanding Consumer and Insurer Behavior (2013) (0)
Premium Variation in the Individual Health (2001) (0)
PHASE I: A QUANTITATIVE EVALUATION OF ADAPTATIONS OF THE TRANSITIONAL CARE MODEL (2017) (0)
4-2011 Insurance and the Demand for Medical Care (2018) (0)
The problems with estimates. (2003) (0)
When Is Medical Care Price Transparency a Good Thing (and When Isn't It)? (2020) (0)
Physician Influence on the Productivity of Hospitals: Empirical Results (1980) (0)
Medical Complexity Mediates Healthcare Resource Use in the Socially Vulnerable (2022) (0)
The Group Insurance Tax Exclusion (2014) (0)
Payment of Medical Providers and the Public Provision of Medical Care (1993) (0)
Insurance and Behavioral Economics: An Introduction to Insurance in Practice and Theory (2013) (0)
Effect of High Deductibles on Spending Growth and Technology Adoption (2020) (0)
Strategies for Dealing with Insurance-Related Anomalies (2012) (0)
Insurance and Behavioral Economics: Anomalies on the Supply Side (2013) (0)
Medicare drug coverage and moral hazard: Currently proposed programs for Medicare drug coverage improvement seem to be much ado about relatively little (2004) (0)
Policy lessons from studying hospital costs. (1985) (0)
Conclusions – A Framework for Prescriptive Recommendations (2012) (0)
The Implementation of Classification Algorithm C4.5 in Determining the Illness Risk Level for Health Insurance Company in Indonesia (2020) (0)
A Ricardian-Demand Explanation for Changing Pharmaceutical R&D Productivity (2016) (0)
Supply-Side Regulation: The Author Replies (2011) (0)
Detecting BS in Health Care 2.0 (2019) (0)
The Availability Effect: Empirical Results (1980) (0)
Full coverage, partial coverage, no coverage for growth hormone treatment: Madison insurance choices as a microcosm (2001) (0)
Reputation and Disenrollment : Role of Consumer Information in Health Insurance Markets (1998) (0)
The Interdisciplinary Nursing Quality Research Initiative (2018) (0)
Cost Effectiveness Analysis and the Design of Cost-Sharing in Insurance: Solving a Puzzle (2012) (0)
Giving Competition in Medical Care and Health Insurance a Chance (2019) (0)
Terrorism Losses and All Perils Insurance † Journal of Insurance Regulation Summer 2005 (2008) (0)
Cost-effectiveness: the authors reply. (2015) (0)
Insurance and new technology (2009) (0)
Moral Hazard Effects (2014) (0)
Editors' Introduction (2004) (0)
Book ReviewSocial Functions and Economic Aspects of Health Insurance (1988) (0)
Subsidizing Health Insurance: Tax Illusion and Public Choice for a Mostly Private Good (2018) (0)
'Responsible National Health Insurance:' The Authors Respond (1991) (0)
Heterogeneity of Consumers' Knowledge, Cognition and Value of Health (2019) (0)
Impact of Financial Policies Market Reform in New Jersey and the Effect on Mortality from Acute Myocardial Infarction (2003) (0)
Improving Value-Based Payment (2020) (0)
Health Policy after a Trump Election Victory. (2020) (0)
The Economics of Patient-Centered Medical Homes (2016) (0)
Financial incentives and drug spending in managed care. (1999) (0)
Health Affairs Disputes The Nongroup Insurance Market : Short On Facts , Long On Opinions And Policy (2002) (0)
The Business of Healthcare and the Economics of Healthcare: Shall Ever the Twain Meet? (2018) (0)
Subject Index Vol. 19, 1999 (1999) (0)
Chapter Three The Realities of the Growth in Medical Spending (2005) (0)
Could a Public Health Insurance Option Lead to More Competitive Markets (2019) (0)
What he should say. Healthcare leaders offer suggestions for state of the union. (2013) (0)
Financing Treatment for Substance Abuse: (496222006-012) (1991) (0)
Health Affairs Choosing Long-Term Care Insurance (2001) (0)
Cost-Effectiveness Analysis of Branded Drugs With Market Demand and Insurance. (2021) (0)
Brief of Amici Curiae Economics Professors in Federal Trade Commission v. Phoebe Putney Health System (U.S. Supreme Court) (2012) (0)
Do Higher Deductibles Slow Health Spending Growth? (2022) (0)
Do Rx drugs cost too much? Choices and consequences. (1997) (0)
ADAPTATIONS OF EVIDENCE-BASED INTERVENTIONS: THE CASE OF THE TRANSITIONAL CARE MODEL (2017) (0)
19. Two Concepts of Equity and Their Implications for Public Policy (2019) (0)
Switching to High-Deductible Health Plans: It Is Going to Be a Bumpy Ride (2018) (0)
Prescription drug formulary design, preferred-product marketshare, and formulary noncompliance: a study of proton-pump inhibitors. (2005) (0)
Accidents with averages (1999) (0)
Can Government Help with the Creatively Unexpected (2018) (0)
Economic Research Initiative on the Uninsured CONFERENCE DRAFT THE UNINSURED : RISK , INCOME , AND “ AFFORDABILITY ” OF COVERAGE Draft : (2004) (0)
Contents Vol. 19, 1999 (1999) (0)
Catastrophic health insurance for the elderly. (1987) (0)
Principles of Economic Analysis of Health Care Technology (1996) (0)
Health Affairs economy ? When does curbing health costs really help the (2001) (0)
Responses to losses in high-deductible health insurance: persistence, emotions, and rationality (2019) (0)
Index to Medical Care Research and Review (1999) (0)
Behavioral and Welfare Effects of Different Types of Insurance (2019) (0)
What Impact Has the U.S. Renal Data System Had on Dialysis Patient Care? (1998) (0)
Consultants for the American Journal of Nephrology 1999 (1999) (0)
Seemed Like a Good Idea (2022) (0)
Editorial: Relaunch of the journal (2015) (0)
It’s technology (and what it is or isn’t worth), stupid! Comments on Aaron’s “It’s Health Care, Stupid! Why Control of Health Care Spending Is Vital for Long-Term Fiscal Stability” (2005) (0)
Objectives for Changing Physician Payment (1989) (0)
Howard Kunreuther: An appreciation (2023) (0)
Universal Health Care : Moving Toward a Single-Payer Approach (2004) (0)
The study protocol to evaluate implementation of the transitional care model in four U.S. healthcare systems during the Covid-19 pandemic (2023) (0)
Hospital Beds (2019) (0)
Reputation and Disenrollment (1998) (0)
Demand for Insurance That Nudges Demand (2014) (0)
Overlapping Generations , Moral Hazard , and the Organization of Medical Partnerships (1998) (0)
ADAPTATIONS OF EVIDENCE BASED TRANSITIONAL CARE MODELS IN THE U.S. (2017) (0)
Insurance and Behavioral Economics: Demand Anomalies (2013) (0)
Competition in the Market for Health Services and Insurance, with Special Reference to the United States (1998) (0)
Purposes of This Book (2012) (0)
Insurance and Behavioral Economics: Innovations in Insurance Markets through Multiyear Contracts (2013) (0)
Organization of Payment (1980) (0)
A Microfinance Approach to Healthcare Distribution (2020) (0)
WHAT FACTORS ARE IMPORTANT WHEN DECIDING TO ADOPT THE EVIDENCE-BASED TRANSITIONAL CARE MODEL (TCM)? (2018) (0)
Insurance and Behavioral Economics: Bibliography (2013) (0)
Conclusions and Policy Implications (1980) (0)
Big Med's Spread. (2023) (0)
Risks And Benefits In Health Care: The View From (2007) (0)
Insuring against catastrophic risks: The role of loss experience and emotions (2018) (0)
Contrasting Ideal and Real Worlds of Insurance (2013) (0)
Bad debts and hospital rate-setting. (1986) (0)
TESTING THE PATIENT-CENTERED MEDICAL HOME PLUS TRANSITIONAL CARE MODEL (2017) (0)
Older Adult and Family Caregiver Perspectives on Engagement in Primary Care. (2022) (0)
BUILDING A TRANSITIONAL CARE MODEL (TCM) POLICY FLIGHT SIMULATOR (2018) (0)
Managing Discovery in the Life Sciences (2018) (0)
What Do Health Insurance Deductibles Do to Health Care Spending Growth and its Efficiency? (2021) (0)
Reform Medicaid First: Laying the Foundation for National Health Care Reform (2009) (0)
Design Principles for Insurance (2012) (0)
In Honor of Uwe Reinhardt: Building on His Health Research & Policy Legacy (2018) (0)
National health insurance: government regulation or consumer choice? (1980) (0)

This paper list is powered by the following services:

Other Resources About Mark V. Pauly

en.wikipedia.org

What Schools Are Affiliated With Mark V. Pauly?

Mark V. Pauly is affiliated with the following schools: